Comparative Dynamics of Delta and Omicron SARS-CoV-2 Variants across and between California and Mexico.


Journal

Viruses
ISSN: 1999-4915
Titre abrégé: Viruses
Pays: Switzerland
ID NLM: 101509722

Informations de publication

Date de publication:
08 07 2022
Historique:
received: 07 06 2022
revised: 29 06 2022
accepted: 04 07 2022
entrez: 27 7 2022
pubmed: 28 7 2022
medline: 29 7 2022
Statut: epublish

Résumé

Evolutionary analysis using viral sequence data can elucidate the epidemiology of transmission. Using publicly available SARS-CoV-2 sequence and epidemiological data, we developed discrete phylogeographic models to interrogate the emergence and dispersal of the Delta and Omicron variants in 2021 between and across California and Mexico. External introductions of Delta and Omicron in the region peaked in early July (2021-07-10 [95% CI: 2021-04-20, 2021-11-01]) and mid-December (2021-12-15 [95% CI: 2021-11-14, 2022-01-09]), respectively, 3 months and 2 weeks after first detection. These repeated introductions coincided with domestic migration events with no evidence of a unique transmission hub. The spread of Omicron was most consistent with gravity centric patterns within Mexico. While cross-border events accounted for only 5.1% [95% CI: 4.3-6] of all Delta migration events, they accounted for 20.6% [95% CI: 12.4-29] of Omicron movements, paralleling the increase in international travel observed in late 2021. Our investigations of the Delta and Omicron epidemics in the California/Mexico region illustrate the complex interplay and the multiplicity of viral and structural factors that need to be considered to limit viral spread, even as vaccination is reducing disease burden. Understanding viral transmission patterns may help intra-governmental responses to viral epidemics.

Identifiants

pubmed: 35891473
pii: v14071494
doi: 10.3390/v14071494
pmc: PMC9317407
pii:
doi:

Types de publication

Journal Article

Langues

eng

Sous-ensembles de citation

IM

Subventions

Organisme : NIDA NIH HHS
ID : R01 DA049644
Pays : United States
Organisme : NIDA NIH HHS
ID : R01 DA055491
Pays : United States
Organisme : NIH HHS
ID : DA049644, AI145555, MH128153 (R01), AI106039 AI106039, MH124590, AI135992, DA049644and DP2 CA051915
Pays : United States
Organisme : NIH HHS
ID : AI306214 and AI100665
Pays : United States

Références

Nature. 2021 Jul;595(7869):713-717
pubmed: 34192736
J Med Virol. 2022 Apr;94(4):1641-1649
pubmed: 34914115
PLoS Comput Biol. 2021 Jan 6;17(1):e1008561
pubmed: 33406072
PLoS Pathog. 2021 May 20;17(5):e1009571
pubmed: 34015049
J Clin Med. 2021 Dec 23;11(1):
pubmed: 35011781
BMC Infect Dis. 2021 Aug 11;21(1):799
pubmed: 34380452
Nature. 2021 Jul;595(7869):707-712
pubmed: 34098568
Science. 2020 Jul 31;369(6503):582-587
pubmed: 32513865
Lancet Infect Dis. 2020 May;20(5):533-534
pubmed: 32087114
EBioMedicine. 2022 Apr;78:103938
pubmed: 35305396
PLoS Pathog. 2014 Feb 20;10(2):e1003932
pubmed: 24586153
Virus Evol. 2017 Aug 03;3(2):vex020
pubmed: 28852573
Science. 2020 May 1;368(6490):493-497
pubmed: 32213647
Cochrane Database Syst Rev. 2021 Mar 25;3:CD013717
pubmed: 33763851
Mol Biol Evol. 2021 Apr 13;38(4):1608-1613
pubmed: 33316043
Math Comput Simul. 2022 Aug;198:65-84
pubmed: 35194306
Virus Evol. 2018 Jun 08;4(1):vey016
pubmed: 29942656
Nature. 2021 Sep;597(7878):703-708
pubmed: 34428777
PLoS Genet. 2015 Aug 12;11(8):e1005421
pubmed: 26267488
Syst Biol. 2018 Sep 1;67(5):901-904
pubmed: 29718447
Science. 2020 Oct 30;370(6516):564-570
pubmed: 32912998
PLoS One. 2022 Jun 17;17(6):e0269306
pubmed: 35714080
Mol Biol Evol. 2008 Jul;25(7):1459-71
pubmed: 18408232
Nature. 2008 May 29;453(7195):615-9
pubmed: 18418375
BMC Res Notes. 2020 Jul 23;13(1):352
pubmed: 32703315
PLoS One. 2022 Apr 21;17(4):e0266844
pubmed: 35446879
MMWR Morb Mortal Wkly Rep. 2021 Jun 25;70(25):922-927
pubmed: 34166331
BMC Evol Biol. 2017 Mar 7;17(1):70
pubmed: 28270091
Science. 2021 Feb 12;371(6530):708-712
pubmed: 33419936
Bioinformatics. 2018 Dec 1;34(23):4121-4123
pubmed: 29790939
Sci Rep. 2021 Aug 11;11(1):16312
pubmed: 34381088
Euro Surveill. 2017 Mar 30;22(13):
pubmed: 28382917
Comput Biol Chem. 2022 Jun;98:107645
pubmed: 35276575
Nature. 2021 Jan;589(7842):337-338
pubmed: 33452508
J Appl Math Comput. 2022 Jan 14;:1-24
pubmed: 35043050
Science. 2021 Aug 20;373(6557):889-895
pubmed: 34301854
PLoS One. 2010 Mar 10;5(3):e9490
pubmed: 20224823
Emerg Microbes Infect. 2022 Dec;11(1):337-343
pubmed: 34935594
MMWR Morb Mortal Wkly Rep. 2022 Feb 11;71(6):206-211
pubmed: 35143464
Science. 2022 Feb 25;375(6583):864-868
pubmed: 35076256
Lancet Infect Dis. 2020 Oct;20(10):1151-1160
pubmed: 32559451
Microb Genom. 2016 Nov 30;2(11):e000093
pubmed: 28348833
J Clin Invest. 2020 Apr 1;130(4):1699-1712
pubmed: 31910162
Cell. 2020 May 28;181(5):997-1003.e9
pubmed: 32359424
Results Phys. 2022 Mar;34:105218
pubmed: 35096520
PLoS Comput Biol. 2009 Sep;5(9):e1000520
pubmed: 19779555
Nat Microbiol. 2020 Nov;5(11):1403-1407
pubmed: 32669681
iScience. 2022 Jul 15;25(7):104575
pubmed: 35720194

Auteurs

Sanjay R Mehta (SR)

Department of Medicine, University of California, San Diego, CA 92093, USA.
Veterans Affairs Health System, San Diego, CA 92093, USA.

Davey M Smith (DM)

Department of Medicine, University of California, San Diego, CA 92093, USA.
Veterans Affairs Health System, San Diego, CA 92093, USA.

Celia Boukadida (C)

Centro de Investigación en Enfermedades Infecciosas, Instituto Nacional de Enfermedades Respiratorias Ismael Cosío Villegas, Ciudad de México 14080, Mexico.

Antoine Chaillon (A)

Department of Medicine, University of California, San Diego, CA 92093, USA.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH